/Companies

ConnectureDRX

Brookfield, US · 3 known investors

Find your way into ConnectureDRX

Sign up to see every warm intro you have to ConnectureDRX

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ConnectureDRX team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ConnectureDRX provides Medicare enrollment and drug transparency technology for health plans, agents, and consumers. The company offers analytics and data-driven solutions to help healthcare organizations engage members and navigate Medicare complexities.

Founders & leadership

LDLea DeVillers
Lea DeVillersGeneral Counsel2010–2020
DADavid A. Sockel
David A. SockelEVP, Strategy and Product Development2015–2018David A. Sockel is Executive Officer at ConnectureDRX, which provides Medicare enrollment and drug transparency technology for health plans, agents, and consumers. He brings experience in revenue creation, go-to-market strategy, product management, and early-stage business development.
JA
Jeffrey A. SurgesExecutive
ME
Mark E. GranvilleExecutive
JP
James P. PurkoChief Financial Officer2011–2016
RD
Robert Douglas SchneiderExecutive
ATAndrew Tutaj
Andrew TutajPresident & EVP
BLBecky Long
Becky LongVP, Customer Success
MMMike Mieure
Mike MieureVP, Technology and SecurityMike Mieure serves as VP of Technology and Security at ConnectureDRX, a healthcare technology company providing Medicare enrollment and drug transparency solutions. He brings experience in IT leadership, technology optimization, project management, and organizational change across complex enterprise initiatives.
DWDavid Weston
David WestonVP, OperationsDavid Weston worked as a software developer in financial services for over a decade, completing projects in equity trading systems and securities infrastructure. He has expertise in data warehousing, ETL, and business intelligence technologies, and is pursuing a master's degree in business intelligence.

Board

EP
Ezra PerlmanBoard director
DADavid A. Jones, Jr.
David A. Jones, Jr.Board directorInvestor at Chrysalis Ventures

Investors · 3

Reported raises · per SEC filings

Form D private placements

$69.5M disclosed across 2 rounds · 2016–2017

▶$17.5MraisedMar 2017 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David A. Jones, Jr.Director
  • David A. SockelExecutive Officer
  • Vickie L. CappsDirector
  • Lea DeVillersExecutive Officer
  • Mark E. GranvilleExecutive Officer
  • Paul KusserowDirector
  • Vincent E. EstradaExecutive Officer
  • Ezra PerlmanDirector
  • Russell S. ThomasDirector
  • A. John AnsayDirector
  • Jeffery A. SurgesExecutive Officer, Director
Offering amount
$17.5M
Amount sold
$17.5M
Finders' fees
$150K
Placement agents
Raymond James & Associates, Inc.
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$52MraisedMay 2016 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Lea DeVillersExecutive Officer
  • David A. SockelExecutive Officer
  • Jeffrey A. SurgesExecutive Officer, Director
  • Ezra PerlmanDirector
  • Mark E. GranvilleExecutive Officer
  • Vickie L. CappsDirector
  • A. John AnsayDirector
  • James P. PurkoExecutive Officer
  • David A. Jones, Jr.Director
  • Robert Douglas SchneiderExecutive Officer
  • Paul KusserowDirector
  • Russell S. ThomasDirector
Offering amount
$52M
Amount sold
$52M
Finders' fees
$1.5M
Placement agents
Raymond James & Associates, Inc.
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Acquisitions · 1

Early investors' stakes continue via these deals
DestinationRx

Developer of drug comparison and purchasing tools; acquired by Connecture in 2013.

Frequently asked questions

What does ConnectureDRX do?
ConnectureDRX provides Medicare enrollment and drug transparency technology for health plans, agents, and consumers. The company offers analytics and data-driven solutions to help healthcare organizations engage members and navigate Medicare complexities.
Who are ConnectureDRX's investors?
ConnectureDRX's investors include Atlanta Technology Angels, Scientia Ventures, Chrysalis Ventures.
How much funding has ConnectureDRX raised?
ConnectureDRX has disclosed $69.5M raised across 2 rounds.
Where is ConnectureDRX headquartered?
ConnectureDRX is headquartered in Brookfield, US.